DAPI (4",6-Diamidino-2-Phenylindole, Dilactate)

Hazard statements (CLP)

H315, H317, H335

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

1272/2008]

Product definition

Mono-constituent substance

CLP CLASSIFICATION

Skin Irrit. 2, H315 Skin Sens. 1, H317 STOT SE 3, H335 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.

Signal word

Warning

Hazard statements

H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H335 - May cause respiratory irritation.

Prevention

P280 - Wear protective gloves. P271 - Use only outdoors or in a well-ventilated area. P261 - Avoid breathing dust.

Response

P304 + P340 + P312 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or physician if you feel unwell.

Storage

P405 - Store locked up.

Disposal

P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.

Hazardous Ingredients

2-phenylindole-4',6-dicarboxamidine dihydrohydrochloride (hydrate)

Supplemental label elements

Not applicable. elements

Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles

Not applicable.

Special packaging requirements

Containers to be fitted Not applicable. with child-resistant fastenings

Tactile warning of danger

Not applicable.

2.3 Other hazards

Substance meets the : No. criteria for PBT according P Not available. B Not available. T No to Regulation (EC) No. 1907/2006, Annex XIII Substance meets the : Not available. criteria for vPvB according to Regulation (EC) No. 1907/2006, Annex XIII

Other hazards which do not result in classification

May form explosible dust-air mixture if dispersed.